TNDM: tandemdiabetes.com Growth-Adjusted Market Cap to Net Income

Symbol and logo of brand tandemdiabetes.com (TNDM)

The P/E and growth ratio valuation of Tandem Diabetes Care (TNDM) demonstrates efficiency dynamics, where the value of 0.00 serves as the current metric. Geopolitical risks and sanctions are limiting sales and chip supplies. Meanwhile, Tandem Diabetes Care is developing smart pumps to automate therapy, while diversified logistics and strategic component reserves ensure the stable production of medical devices.

Tandem Diabetes Care (TNDM) - PEG Multiple from 07/04/2022 to 11/16/2026

Tandem Diabetes Care, Inc. (TNDM) - metric breakdowns and financial figures

- current price and projected stock value:
Fundamental company analysis:TNDM (Tandem Diabetes)
Manufactured products of tandemdiabetes.com

Tandem Diabetes Care (TNDM) patent-protected intellectual property in the AI pump sector determines the balance between the P/E multiple and growth. This ratio compares the market value of earnings to their growth rate, where a value below one signals that the asset is undervalued relative to its expansion, allowing investors to identify potentially high-yield securities amid strict FDA regulatory control.

Competing companies

Growth-Adjusted Market Cap to Net Income Boston Scientific|PEG Multiple EW (Edwards)|RMD (ResMed Inc.) - Market Cap to Earnings and Growth Ratio|PODD: Price/Earnings to Growth Multiple|Price to Earnings Adjusted for Growth Rate Zimmer Biomet Corp|COO: PEG Multiple|Price to Earnings Adjusted for Growth Rate Align Technology Inc (ALGN)|GMED (Globus Medical) - PEG Multiple|Growth-Adjusted P/E Ratio TMDX (TransMedics Group Inc)|Price/Earnings to Growth Multiple ATEC (Alphatec)|AORT (CryoLife) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Enovis Inc. ENOV|IART - Price/Earnings to Growth Multiple|Establishment Labs Corp - PEG Multiple|Price to Earnings Adjusted for Growth Rate Beta Bionics Inc|IRMD: PEG Multiple|Growth-Adjusted P/E Ratio EMBC|AXGN (Axogen Surgical) - PEG Multiple|SI-BONE Corp (SIBN) - Growth-Adjusted Market Cap to Net Income|PEG Multiple OFIX|PEG Multiple bioventus.com (BVS)|PEG Multiple KIDS (OrthoPediatrics Corp)|PEG Multiple Treace Medical Concepts Inc TMCI|SRTA - Price/Earnings to Growth Ratio|CARL: Price/Earnings to Growth Ratio|RXST (RxSight, Inc.) - Price/Earnings to Growth Multiple|ClearPoint Neuro Inc. - Growth-Adjusted Payback Ratio|STXS (Stereotaxis Corporation) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Neuronetics Inc. STIM|Price/Earnings to Growth Ratio Sight Sciences Inc. (SGHT)|Orchestra BioMed, Inc. (OBIO) - Price to Net Income Growth Ratio|Anika Therapeutics Inc. - Price/Earnings to Growth Multiple|PEG Multiple InspireMD, Inc. NSPR|Jin Medical International Ltd. - PEG Multiple|Growth-Adjusted Market Cap to Net Income Vivani Medical VANI|Xtant Medical (XTNT) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio NMTC (NeuroOne Medical Technologies Corp.)|Price/Earnings to Growth Ratio modular-medical.com|Price to Earnings Adjusted for Growth Rate myomo.com MYO|PEG Multiple COCH|VVOS - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio enVVeno Medical NVNO|SINT: Growth-Adjusted P/E Ratio|TNON: Price/Earnings to Growth Multiple|rewalk.com - Company Value to Earnings Growth Ratio|AMIX: PEG Multiple|Growth-Adjusted P/E Ratio IVF|Price/Earnings to Growth Ratio bonebiologics.com|Growth-Adjusted P/E Ratio AXNX (Axonics, Inc)|Price/Earnings to Growth Ratio BIOLASE Inc. (BIOL)|Dynatronics - Growth-Adjusted P/E Ratio|PEG Multiple FNA (Paragon 28 Corp)|invobioscience.com (INVO) - Price to Earnings Adjusted for Growth Rate